Cabozantinib plus atezolizumab in previously untreated advanced hepatocellular carcinoma and previously treated gastric cancer and gastroesophageal junction adenocarcinoma: results from two expansion cohorts of a multicentre, open-label, phase 1b trial (COSMIC-021)
-
Published:2024-01
Issue:
Volume:67
Page:102376
-
ISSN:2589-5370
-
Container-title:eClinicalMedicine
-
language:en
-
Short-container-title:eClinicalMedicine
Author:
Li Daneng,
Loriot Yohann,
Burgoyne Adam M.,
Cleary James M.,
Santoro Armando,
Lin DanielORCID,
Aix Santiago Ponce,
Garrido-Laguna Ignacio,
Sudhagoni Ramu,
Guo Xiang,
Andrianova Svetlana,
Paulson Scott